Abemaciclib for the Treatment of Luminal Metastatic breAst caNcer in the Real-life Clinical pracTice in Russia.
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: HR+/HER2- Breast Cancer|Metastatic Disease|Аdvanced Disease
Interventions: DRUG: Abemaciclib|DRUG: Abemaciclib|DRUG: Abemaciclib
Sponsor: Blokhin's Russian Cancer Research Center
Collaborators: Russian Society of Clinical Oncology